Study on the Mechanism of Acquired Resistance of Entrectinib

NCT07199959 · clinicaltrials.gov ↗

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

ROS1 Fusion Positive
Non Small Cell Lung Cancer

Interventions

PROCEDURE: venipuncyure
DRUG: Entrectinib

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]